BST2/tetherin inhibits the release of enveloped viruses from cells. Primate lentiviruses have evolved specific antagonists (Vpu, Nef, and Env). Here we characterized tetherin proteins of species representing both branches of the order Carnivora. Comparison of tiger and cat (Feliformia) to dog and ferret (Caniformia) genes demonstrated that the tiger and cat share a start codon mutation that truncated most of the tetherin cytoplasmic tail early in the Feliformia lineage (19 of 27 amino acids, including the dual tyrosine motif). Alpha interferon (IFN-␣) induced tetherin and blocked feline immunodeficiency virus (FIV) replication in lymphoid and nonlymphoid feline cells. Budding of bald FIV and HIV particles was blocked by carnivore tetherins. However, infectious FIV particles were resistant, and spreading FIV replication was uninhibited. Antagonism mapped to the envelope glycoprotein (Env), which rescued FIV from carnivore tetherin restriction when expressed in trans but, in contrast to known antagonists, did not rescue noncognate particles. Also unlike the primate lentiviral antagonists, but similar to the Ebola virus glycoprotein, FIV Env did not reduce intracellular or cell surface tetherin levels. Furthermore, FIV-enveloped FIV particles actually required tetherin for optimal release from cells. The results show that FIV Envs mediate a distinctive tetherin evasion. Well adapted to a phylogenetically ancient tetherin tail truncation in the Felidae, it requires functional virion incorporation of Env, and it shields the budding particle without downregulating plasma membrane tetherin. Moreover, FIV has evolved dependence on this protein: particles containing FIV Env need tetherin for optimal release from the cell, while Env ؊ particles do not.
T
he type I interferon (IFN-I)-inducible factor BST2/tetherin/ CD317/HM1.24 inhibits cell surface release of a diverse set of enveloped viruses that include retroviruses (1) (2) (3) (4) (5) , filoviruses (2, 6, 7) , the arenavirus Lassa virus (7) , and the DNA virus Kaposi's sarcoma-associated herpesvirus (KSHV) (8) . Viruses have evolved antagonists that sequester tetherin away from the cell surface or directly induce its degradation through proteasomal or lysosomal pathways (for reviews, see references 9, 10, and 11). For primate lentiviruses, three different viral proteins are known to antagonize tetherin restriction: Vpu (HIV-1, SIVmus/gsn/mon) (4, 5, (12) (13) (14) , Nef (several simian immunodeficiency virus [SIV] strains) (13) (14) (15) (16) , and Env (HIV-2, SIVtan) (3, 17, 18) .
The antiviral phenotype that prompted the search for tetherin, restricted HIV-1 particle release from the plasma membrane, was observed over 20 years ago (19, 20) . Tetherin contains a short cytoplasmic N terminus with dual Yxx⌽ motifs that mediate clathrin-dependent endocytosis (21) , a single-pass transmembrane domain, an ectodomain that contains two N-linked glycosylation sites (22) as well as three cysteines that participate in intermolecular disulfide bonds (22, 23) , and a C-terminal glycosylphosphatidylinositol (GPI) anchor (24) . These distinctive features suggested that tetherin exerts its antiviral function by connecting cellular and viral membranes. This mechanism has been supported by immunoelectron microscopy (25) (26) (27) and by evidence that antiviral function is preserved if the component domains are substituted with structurally similar domains from other proteins (27) . Recent experiments have clarified the topology involved: viral and plasma membranes are infiltrated by opposite ends of a parallel tetherin homodimer, with a severalfold preference for insertion of the transmembrane domains into the cell membrane and the GPI anchors into the virion (28) . Thus, each protein monomer operates, within a dimer, as an end-to-end tether between cell and virus.
The domestic dog, cat, and ferret lack functional antiviral TRIM5alpha and TRIMCyp genes (29) (30) (31) , leaving them without a version of the important postentry capsid-targeting systems that restrict retroviruses in the cells of numerous primates (32) (33) (34) (35) ; there is similarly no known carnivore equivalent to the mouse Fv1 gene (36) . The cat does have an effective APOBEC3 protein repertoire, which is antagonized by feline immunodeficiency virus (FIV) Vif and feline foamy virus Bet (37) (38) (39) (40) (41) . FIV particle release is also inhibited by human tetherin (2) , but FIV does not encode homologues of Vpu or Nef.
Two different tetherin cDNAs generated from Felis catus mRNA transcripts have been tested (42, 43) . The two predicted proteins have dissimilar N termini. Dietrich et al. reported a 186-amino-acid sequence for feline tetherin, which we here refer to as Felis catus tetherin long form (fcTetherin LF ). The N-terminal 19 amino acids align well with the N termini of primate tetherin proteins. In contrast, a truncated form, here termed Felis catus tetherin short form (fcTetherin SF ), lacks these 19 N-terminal amino acids (43, 44) . The difference is potentially important because N termini of primate tetherin proteins contain highly consequential motifs. For example, deletion of the N-terminal 20 amino acids of human tetherin results in a protein with altered patterns of glycosylation and subcellular trafficking and absent antiviral activity against HIV-1 (4). Furthermore, rhesus macaque tetherin residues 14 to 18 determine Nef antagonism, and the absence of these 5 amino acids in the human tetherin N terminus drove the evolution of HIV-1 Vpu (13, 15, 16 ; see references 45 and 10 for reviews). Additional debate concerns whether FIV encodes a tetherin antagonist or has been otherwise selected to evade the protein. A recent study reported that FIV Env can ameliorate tetherin restriction (44) , although this was not observed by Dietrich et al. (42) . Cell lines. MCC cells are a feline large granular lymphoma cell line (46); Crandell feline kidney (CrFK) cells are an adherent cell line derived from feline kidney (47) . Mya-1 cells are an interleukin-2 (IL-2)-dependent T cell line (48) . Cell lines were maintained in Dulbecco's modified Eagle medium (DMEM) or RPMI medium supplemented with 10% fetal calf serum (FCS), penicillin-streptomycin, and L-glutamine. KE-R cells were a gift of Carsten Münk. Mya-1 cells were additionally cultured with 20% FCS, 10% D-glucose, 1% sodium bicarbonate, 1% sodium pyruvate, 1% nonessential amino acids (NEAA), and 0.1% ␤-mercaptoethanol. Feline peripheral blood mononuclear cells (PBMCs) were purified by Ficoll centrifugation from whole blood and maintained in RPMI medium supplemented with 10% FCS, 2 mM glutamine, 1 mM sodium pyruvate, essential and nonessential amino acids, 10 mM HEPES, 0.05 mM ␤-mercaptoethanol, phytohemagglutinin E (PHA-E; 2 g/ml), and human IL-2 (in conditioned medium from murine L2.23 feeder cells, which were a kind gift of T. Miyazawa). PHA-E was discontinued 48 h after isolation. For FIV replication assays in IFN-treated cells, 1 ng/ml human IFN-␣ (hIFN-␣; Sigma) was added 24 h before infection and maintained for the duration of the experiment.
MATERIALS AND METHODS

Use
Isolation of tetherin cDNAs and 5= RACE. A table that details all oligonucleotides used in this work is available on request. cDNAs corresponding to fcTetherin LF , accession no. NM_001243085 (42) , and fcTetherin SF , accession no. DDBJ AB564550 (43) , were amplified by reverse transcriptase PCR (RT-PCR) from mRNA of feline PBMCs pretreated with 1,000 U/ml rat IFN-␣ (Sigma). A dog tetherin cDNA was isolated by RT-PCR using mRNA of D17 cells, also pretreated with 1,000 U/ml rat IFN-␣. Total RNA was collected with the RNeasy Plus Minikit (Qiagen) and converted to cDNA with Transcriptor First Strand cDNA Synthesis (Roche). Tetherin cDNAs were amplified using species-specific primers, blunt ligated into pSC-B amp/kan (Agilent), and confirmed by sequencing. For 5= rapid amplification of cDNA ends (RACE), total RNA was collected as described above from domestic cat, tiger, and ferret PBMCs as well as from canine D17 and feline K-ER and CrFK cells. 5= half segments of tetherin transcripts were determined using the FirstChoice RLM-RACE kit (Applied Biosciences) according to the manufacturer's instructions. Tetherin-specific primers were used. Nested products were isolated on agarose gels and blunt ligated using the StrataClone Blunt PCR cloning kit (Agilent). Six to 10 clones were sequenced for each species, and only clones containing the intact 36-bp 5= RACE adapter were included for later comparison.
Plasmid constructions and generation of stable cell lines. Briefly, p1012 HIV-1 IN-myc-IRES-puro (49) was partially digested with KpnI, and a 1.5-kbp fragment containing IRESpuro was isolated and inserted into the KpnI site in Tsin poly (50) to create Tsin-IRESpuro. Tsin-HA-tetherin-IRES-puro was created by PCR amplifying BglII/ClaIflanked tetherin and cloning into a BamHI/ClaI-digested Tsin-IRESpuro. Tsin tetherin-HA was constructed by overlap extension PCR of a BamHI/ ClaI (human and canine)-or BglII/ClaI (feline LF/SF )-flanked tetherin to insert an HA tag internally within the tetherin open reading frame (ORF) (immediately after amino acid 154, 158, or 159 of human, canine, or feline LF tetherin, respectively) before insertion in a BamHI/ClaI-digested Tsin-IRESpuro backbone. Stable cell lines were generated by transducing targets and selecting in puromycin (3 g/ml for 293T cells, 0.5 g/ml for K-ER cells, or 5 g/ml for CrFK cells). pHIV-1 luc ⌬Vpu was created by exchanging a SalI/KpnI fragment of pNL4.3 ⌬Vpu containing a frameshifted vpu into pNL4.3R-E-⌬426 (pHIV-1 luc ) (51) . pCT5 (52, 53) encodes replication-competent FIV 34TF10 (54) . The truncated OrfA of pCT5 (43 amino acids) was repaired, changing a stop codon to Trp and resulting in the production of a 78-residue protein in pCT5
Aϩ , which produces the virus FIV 34TF10Aϩ when transfected into human cells (55) . Two pCT5-analogous constructs that allow production of FIV particles in human cells were created for the PPR and C36 clones of FIV. pCT-PPR was constructed similarly to pCT5 (52, 53) from FIV PPR in order to replace the 5= FIV U3 element with the cytomegalovirus (CMV) immediate early promoter. pCT-C36
Aϩ was created in two steps. First, an Msc1-Eco47III fragment of FIV C36 Clone C was ligated into the Msc1-Eco47III-digested pCT-PPR backbone. The intermediate from step 1 was then linearized with MscI, and an MscI-MscI fragment from FIV C36 Clone C was inserted and screened for proper orientation by sequencing. pCT-C36 thus contains PPR LTR elements but is otherwise entirely C36 from the 33rd Gag nucleotide to the middle of the 3= U3 element. Only one amino acid is different from C36, a V-to-M change at amino acid 11 of Gag. FIV Envelope expression plasmids (pFE) were constructed by PCR amplification of NotI/SalI-flanked Env from pCT-PPR or pCT-C36. This PCR extended from the first codon of Env to the end of the RRE. PCR amplicons were digested with NotI/SalI and cloned into a NotI/SalI-digested FP93 backbone, which replaces Gag-Pol, but not Rev. Single-cycle and replicating FIV stocks. Previously described methods were used to generate viral stocks (56, 57) by 293T cell transfection. FIV 34TF10 was produced in 293T cells by transfection of pCT5 (52, 53) or pCT5
Aϩ . Similarly, FIV PPR and FIV C36 were produced by 293T transfection of pCT-PPR and pCT-C36 Aϩ , respectively. When indicated, viruses were first-round vesicular stomatitis virus G glycoprotein (VSV-G) pseudotyped by cotransfection with pMD.G (VSV-G). Viral stocks were filtered (0.45 m), and their titers were determined on CrFK cells by a focal infectivity assay (52) . Viral replication was monitored by RT activity (57) . Mean RT activity Ϯ SD from duplicate measurements for each sample was calculated.
Real-time PCR quantification of tetherin cDNA. Total RNA was isolated using a Qiagen RNeasy Plus Minikit after treatment for 24 h with hIFN-␣ (1 ng/ml, Sigma) or control vehicle. cDNA was generated from 5 g of total RNA using Transcriptor First Strand cDNA Synthesis (Roche) for real-time PCR. Two microliters cDNA was quantified against a serially diluted plasmid standard using a Roche 480 LightCycler and Roche LCDA software. Feline glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH) was quantified in parallel. LightCycler programs included an initial denaturation step at 95°C for 10 min and a melting step after amplification (65°C to 97°C; temperature transition rate, 0.11°C/s). Tetherin or IRF7 cDNA was amplified using 500 nM sense primer and 500 nM antisense primer. PCR amplification and analysis were performed as follows: for tetherin, 95°C for 10 s, 57°C for 10 s, and 72°C for 17 s for 45 cycles, with temperature transition rate of 4.4°C/s; for IRF7, 95°C for 10 s, 57°C for 10 s, and 72°C for 6 s for 45 cycles, with temperature transition rate of 4.4°C/s; for GAPDH, 95°C for 10 s, 53°C for 10 s, and 72°C for 17 s for 45 cycles, with temperature transition rate of 4.4°C/s. Triplicate RNA isolations were performed for each treatment group of each cell line (n ϭ 1 for PBMCs), and samples was measured in triplicate (tetherin gene) or in duplicate (GAPDH, IRF7); a two-tailed t test was performed between control and treated groups.
NF-B induction by tetherin. 293T cells (2.5 ϫ 10 4 ) were seeded in a 96-well plate and allowed to adhere overnight. Cells were polyethyleneimine (PEI) transfected in triplicate with pNFB(3x)-Firefly luciferase, pTAL-Gaussia luciferase, pCG-tetherin-IRES-dsRed2, and pCG-HIV-1M-vpu-IRES-eGFP at a 4:1:1.6:4 ratio with 150 ng total DNA in each well (58) . Forty-eight hours after transfection, gaussia and firefly luciferase activities were measured in the supernatant and cells, respectively. Gaussia luciferase was used to control for transfection efficiency, and NF-B induction was compared for tetherin-transfected versus control transfected cells.
Indirect immunofluorescence, laser scanning confocal microscopy. Localization experiments were performed using previously described methods (50) with variations described below. Briefly, 1 ϫ 10 5 cells were plated in LabTek II chamber slides, allowed to adhere overnight, fixed with 4% (wt/vol) paraformaldehyde, permeabilized with methanol (unless otherwise stated), stained with 4=,6-diamidino-2-phenylindole (DAPI), and imaged by laser scanning confocal fluorescence microscopy. Imaging of cell surface tetherin expression was performed by calcium phosphate transfection of 2 ϫ 10 5 293T cells with 1 g tetherin-HA expression plasmids, 1.5 g pCT5
Aϩ , pCT-PPR, or pCT-C36 Aϩ , and Tsin poly (stuffer) to bring the total amount of DNA to 2.5 g in each well. Cells were washed 16 h after transfection, and after an additional 24 h cells were fixed, stained, and imaged as described above. Antibodies used were rat monoclonal anti-HA (Roche), Alexa Fluor 594-conjugated goat antirat (Invitrogen), cat anti-PPR serum, and fluorescein isothiocyanate (FITC)-conjugated goat anti-cat (Santa Cruz Biotech) antibodies.
Particle release assays. 293T cells were PEI transfected with 1.5 g the packaging constructs pHIV-1 Luc (51), pHIV-1 Luc ⌬Vpu, pFP93 (FIV [59] ), pCT-PPR, pCT-C36 Aϩ , or the indicated viral mutant. Cells were washed 8 h later and harvested after an additional 48 h. Cell lysates were collected in radioimmunoprecipitation assay (RIPA) buffer (150 mM NaCl, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate, 1% NP-40, 150 mM Tris-HCl, pH 8.0) plus protease inhibitors (complete-Mini; Boehringer). Supernatants were filtered (0.45 m). Equivalent amounts of supernatant and cell lysates were immunoblotted for HIV-1 CA using the 39/5.4A monoclonal antibody (MAb; Abcam) or FIV CA using feline serum reactive to PPR (a gift of Peggy Barr). Blots were stripped and reprobed with rat ␣-HA (Roche) and mouse anti-alpha-tubulin (Sigma) monoclonal antibodies. RT activity was also quantified as described above. CrFK particle release assays were performed as described above, except transduction by indicated single-round VSV-G-pseudotyped vectors produced in 293T cells was used in lieu of transfection. A total of 2.5 ϫ 10 4 cells were plated in a 24-well plate and allowed to adhere overnight before being transduced with equivalent volumes of vector. Cells were washed 3 times after 24 h and then 72 h after transduction supernatants and cell lysates were harvested as described above. Envelope antagonism experiments were performed by 293T PEI transfection as described above with 750 ng viral packaging construct (pHIV-1 Luc ⌬Vpu or pCT5efs) and 750 ng VSV-G, pFE-PPR RRE , pFE-C36 RRE , pEbolaGPmyc (myc-tagged Ebola virus glycoprotein [60] ), or pCDNA3.1 (stuffer). Ebola virus glycoprotein (GP) expression was detected by immunoblotting with polyclonal rabbit anti-Ebola virus sera.
Pseudotyped lentiviral vector titers. Green fluorescent protein (GFP)-expressing HIV-1 vectors were produced by PEI cotransfection of 3 ϫ 10 5 293T cells with 600 ng HIV-1 packaging construct pCMV-⌬R8.9, 600 ng HIV-1 GFP transfer construct TSinG (51), and 200 ng envelope plasmid (pMD.G [VSV-G], pFE-PPR, or pFE-C36 Aϩ ). GFP-expressing FIV vectors were similarly produced with 600 ng pFP93, 600 ng FIV GFP transfer construct GiNSIN (61), and 200 ng envelope. Cells were washed 8 h after transfection, and after an additional 48 h supernatant was filtered (0.45 m), and titers were determined on CrFK cells expressing feline CD134 (fCD134). Titers are shown as transducing units (TU) per ml. Reverse transcriptase activity of vectors was also measured as described above.
Flow cytometry for intracellular and cell surface tetherin. For intracellular tetherin degradation experiments, CrFK cells were plated in a 24-well plate, allowed to adhere overnight, and infected with FIV. Sixteen hours later cells were washed, and 48 h later cells were fixed with 4% (wt/vol) paraformaldehyde, permeabilized with methanol, and stained for FIV proteins (cat anti-PPR serum primary and goat anti-cat phycoerythrin [PE]-conjugated [Santa Cruz Biotech] secondary antibodies) and tetherin (rat anti-HA primary and goat anti-rat Alexa Fluor 488-conjugated [Invitrogen] secondary antibodies). Tetherin and FIV expression was then analyzed using a FACScan (BD Biosciences) and CellQuest (Becton, Dickinson) software. Fluorescence-activated cell sorting (FACS) for cell surface tetherin levels was performed on clonal 293T cells expressing internally epitope-tagged tetherin. Cells were PEI transfected with 100 ng pEGFP-N1 and 1.4 g of pCDNA3.1(Ϫ), pCDNA3.1vphu (62) , pFE-PPR RRE , pFE-C36 RRE , pCT-PPR, or pCT-C36 Aϩ . Cells were washed 8 h after transfection, and after an additional 48 h cells were trypsinized, washed with phosphate-buffered saline (PBS), and stained for HA (rat anti-HA primary and goat anti-rat Alexa Fluor 594-conjugated [Invitrogen] secondary antibodies), and dual-color FACS was run on an LSRII (Becton, Dickinson). Analysis was performed by gating for GFP-positive cells and comparing mean fluorescence intensity (MFI) of Alexa Fluor 594.
RESULTS
Effects of type I IFN on FIV replication.
We observed that human IFN-␣ treatment blocked FIV replication in primary feline PBMCs (Fig. 1A) . We then tested IFN-␣ antiviral effects in a panel of domestic cat cell lines and observed clear differences. Viral replication was completely suppressed in the adherent cell line K-ER and in the IL-2-dependent T cell line Mya-1 ( Fig. 1B and C) . In contrast, replication was inhibited but not abrogated in a second adherent feline cell line, CrFK (Fig. 1D) , and in the lymphoma cell line MCC peak viral production was nearly the same in the presence and absence of IFN-␣ (Fig. 1E ). Type I interferon inhibition of HIV-1 replication (63) is due at least in part to upregulated expression of host cell restriction factors, including tetherin (4, 5, 64) . To determine whether feline tetherin induction could be playing a role in the patterns of viral suppression shown in Fig. 1 , we proceeded to assess the IFN-␣ inducibility of feline tetherin mRNA in different feline cells and to clone, sequence, and express cDNAs for both reported Felis catus isoforms (42, 43) as well as for Canis familiaris tetherin. The purpose of characterizing the dog mRNA and protein was to encompass both main branches of the Carnivora (Caniformia and Feliformia).
Carnivore tetherins. cDNAs for fcTetherin LF and fcTetherin SF (corresponding to cBST2* and cBST2 504 , respectively, in the study by Celestino et al. [44] ) were amplified by RT-PCR from mRNA of feline peripheral blood mononuclear cells (PBMCs) that we pretreated with 1,000 U/ml rat IFN-␣ (rIFN-␣). A Canis lupus familiaris tetherin cDNA (cfTetherin) was similarly isolated from rIFN-␣-treated canine DK cell mRNA using primers designed from BLAT searches of the dog genome. In Fig. 2A , the deduced protein sequences are aligned with the human tetherin sequence.
Although the carnivore proteins have limited overall homology with human tetherin (46% and 43% amino acid identity for fcTetherin LF and cfTetherin, respectively), residues known to be important for proper dimerization, glycosylation, and trafficking of the human protein to and from the cell surface are conserved, with the exception of a variance at one of the positions of N-linked glycosylation and the absence of the dual-tyrosine-based endocytosis motif in fcTetherin SF . As expected, the two carnivore tetherins share greater amino acid identity with each other (60%) than with human tetherin. Interrogation of the domestic cat genome assembly did not identify an open reading frame that corresponds directly to the suggested (42) fcTetherin LF (Fig. 2B) . However, splicing could generate an mRNA that encodes this putative longer isoform. To clarify the issue, we performed 5= RACE on mRNA from Felis catus PBMCs and cell lines, which identified only transcripts corresponding to fcTetherin SF (Fig. 2B) . We also cloned and sequenced tiger (Panthera tigris) and ferret (Mustela putorius furo) tetherin cDNAs. Alignment of tiger, cat, dog, and ferret tetherin sequences, the last two representing Caniformia (Canidae and Mustelidae, respectively), revealed a felid-specific single-nucleotide deletion at the codon corresponding to the initiator methionine of fcTetherin LF (Fig. 2B, arrow) . The presence of this deletion in both the tiger and the domestic cat genes suggests that it occurred after the Caniformia-Feliformia split, around 43 to 60 million years ago (MYA) (65) , but before the modern felid species radiation in the late Miocene began, approximately 11 MYA (66). The AG dinucleotide generated by the T nucleotide deletion could theoretically act as a splice acceptor to bring an upstream ATG into the frame here, but we found no evidence for this in repeated RACE experiments using primary and immortalized feline cells (data not shown).
Using primers that amplify across exon boundaries of the BST2 gene transcript, quantitative real-time PCR was performed on mRNA collected from a variety of canine and domestic cat cell lines. Consistent with the IFN-␣ inducibility of human tetherin (4), treatment of feline cells with human IFN-␣ resulted in marked upregulation of tetherin transcripts in cells of lymphoid and Canis familiaris tetherins. Highlighting indicates residues implicated by prior studies in human tetherin trafficking and multimerization (21-24, 27, 95, 96) . (B) mRNA sequences determined by 5= RACE. Underlined codons and numbering refer to putative fcTetherin LF (M1) and fcTetherin SF initiator methionines. (C to E) Analysis of tetherin mRNA expression and IFN upregulation was performed in domestic cat cell lines (C), cat PBMCs (D), and canine cell lines (E); data are presented as copies of tetherin cDNA per 10 5 copies of GAPDH cDNA Ϯ SD; n ϭ 9 experiments except for PBMCs, where n ϭ 3 for each donor. *, P Ͻ 0.01; **, P Ͻ 0.001. (F) Primers amplifying a conserved region of IRF-7 were used to analyze IRF-7 expression in samples collected as described for panels C and E. *, P Ͻ 0.01; **, P Ͻ 0.001. (G) Tetherin-induced NF-B induction was determined in 293T cells by cotransfection of an NF-B-driven (3 NF-B binding sites) firefly luciferase construct, a control promoter-driven gaussia luciferase, tetherin expression constructs, and HIV-1 M Vpu or control plasmids. Fold induction of NF-B-driven firefly luciferase is displayed as the average of three independent transfections Ϯ SD.
(Mya-1, FeT-J) and nonlymphoid (CrFK, K-ER) origin (Fig. 2C) . Feline PBMCs also exhibited IFN-␣-inducible tetherin expression at a level comparable to that seen in human PBMCs, yielding 5.9-and 13.6-fold induction, respectively, from two different donors (Fig. 2D) . In contrast, IFN-␣ treatment did not result in tetherin induction in a canine osteosarcoma (D17) or kidney cell line (DK) (Fig. 2E) . The MCC lymphoma cell line was the only feline cell line tested in which IFN-␣ did not substantially inhibit FIV replication (Fig. 1E) , and it was also the cell line in which IFN-␣ induction of tetherin mRNA was least, although the absolute mRNA levels were lower in CrFK cells. This failure to substantially induce tetherin in MCC cells appears to reflect a deficit in the IFN-␣ signaling pathway because IRF-7, an IFN-␣-inducible transcription factor (67) recently found to boost tetherin upregulation in mice (68), was also not upregulated by IFN-␣ treatment in these cells (Fig.  2F) . Likewise, the canine cell lines did not exhibit IRF-7 upregulation, correlating with a lack of tetherin mRNA induction (Fig. 2E  and F) .
Before it was implicated in defense against enveloped viruses, human tetherin was identified in a large-scale cDNA library expression screen for NF-B-activating proteins (69) . Recent evidence for discordant NF-B signaling between human tetherin isoforms that differ only in cytoplasmic tail length suggests that tetherin may mediate complex signal transduction activities and act as an antiviral sensor that triggers proinflammatory gene expression (70) . Specifically, the YxY clathrin adaptor binding motif located in the cytoplasmic tail of the longer human isoform was found to be critical for NF-B signaling (70) (71) (72) . To test whether carnivore tetherins induce NF-B signaling and whether the cytoplasmic tail truncation of feline tetherin may impact this, we compared cfTetherin and fcTetherin SF to human tetherin for their ability to activate a minimal NF-B promoter in 293T cells. Neither carnivore tetherin was found to activate NF-B signaling under these conditions (Fig. 2G) .
Subcellular localization of feline and canine tetherins. We expressed each of the four tetherins stably in 293T cells and per- formed confocal immunofluorescence microscopy (Fig. 3A) . We included fcTetherin LF here and subsequently in order to test whether its 19 N-terminal amino acids, which we speculate might have formed the N terminus of an ancestral feline tetherin protein, confer altered bioactivity. Each protein displayed a similar intracellular distribution, with abundant cytoplasmic foci and detectable plasma membrane-localized protein, which is consistent with the pattern described previously for the human protein (4). In contrast, in the feline cell line CrFK, tetherin was detected predominantly in cytoplasmic inclusions, with little visible accumulation at the plasma membrane (Fig. 3B) . The exception was fcTetherin SF , which had slightly increased levels of diffuse and plasma membrane-localized tetherin, suggesting functional capacity of the 19-amino-acid tail to mediate recycling from the cell surface. Stable expression in a second feline cell line, KE-R (Fig.  3C) , revealed similar distributions for each tetherin.
Though little ectopically expressed tetherin was generally detected at the plasma membrane of feline cell lines in standard confocal images, the protein may accumulate at the cell surface in amounts that are less easily discerned when abundant intracellular tetherin is coimaged. Therefore, we inserted an epitope tag into the extracellular portion of the protein, according to the strategy of Perez-Caballero et al. (27) , and analyzed feline cell surface accumulation. While tetherin was again visible predominantly in intracellular accumulations in permeabilized cells, in nonpermeabilized cells cell surface tetherin was clearly visible (Fig. 3D) . These results indicate that the protein does indeed traffic to the surface of these feline cells, even though the protein present there in the steady state may be a relatively small fraction of the total cellular pool.
Carnivore tetherins restrict lentiviral budding. In order to test the antiviral properties of carnivore tetherins, we used lentiviral vectors to generate stable epitope-tagged tetherin-expressing lines from 293T cells, which express negligible endogenous tetherin. We derived single-cell clones and used two independent clones for each protein in further experiments (Fig. 4A ). Viral expression constructs used here and in subsequent experiments are diagrammed in Fig. 4B and are denoted as pFIV when referring to direct expression from transfected plasmid and as FIV when viral particles produced from these vectors are used to infect fresh cells. Similar to the human protein, canine and feline tetherins reduced the accumulation of Vpu-deficient HIV-1 virus-like particles (VLPs) in supernatant to background levels (Fig. 4C) . Consistent with the limited transmembrane domain conservation between human and carnivore tetherins ( Fig. 2A) , Vpu was able to rescue HIV-1 budding in cells expressing human tetherin but had no effect at all in cells expressing feline or canine tetherin (Fig. 4C) . Budding of FIV VLPs (53, 73) was similarly restricted by all of the tetherins, though canine tetherin was less effective than human or feline tetherins (Fig. 4D) . For both viruses, the shorter form of feline tetherin, which our evidence indicates is the natural one in present-day felids (Fig. 2B) , and the artificially longer form had similar antiviral properties, indicating that inclusion of the putative ancestral N-terminal cytoplasmic tail including the endocytosis motif does not augment antiviral function.
Budding of infectious FIV is not affected by tetherin. To further characterize the effects of feline tetherin on replication-competent, wild-type FIV, we generated CrFK cell lines that stably express the protein. Levels of endogenous tetherin mRNA in CrFK cells, which we assessed by GAPDH (glyceraldehyde-3-phosphate dehydrogenase) mRNA-normalized quantitative RT-PCR, were extremely low, and the peak level after IFN induction was also the lowest in any line that we examined (Fig. 2C) , making it a good substrate for stable ectopic expression. Single-cell clones were generated, with two independent clonal lines for each tetherin used in further analyses (Fig. 5A) . Cells that express fcTetherin SF had substantially increased protein levels compared to fcTetherin LF or cfTetherin despite the presence of similar numbers of mRNA transcripts for each protein (Fig. 5B) , suggesting that the N-terminal cytoplasmic tail of fcTetherin LF either reduces translation or, more likely, increases the protein's turnover rate through enhanced internalization.
These cell lines were infected with a ⌬Vpu HIV-1 reporter virus, and the supernatants were assayed for de novo VLP accumulation. Similar to what was observed in the human cells, each of the tetherins effectively inhibited VLP accumulation (Fig. 5C ). Variation was evident in the supernatant p24 levels, which may reflect differences in tetherin expression levels between cell clones (the first Homo sapiens [hs] tetherin lane in Fig. 5A corresponds to the first H. sapiens tetherin lane in Fig. 5C ).
CrFK cells do not express the primary FIV receptor CD134, which restricts spreading replication in these cells to laboratoryadapted strains that can use the coreceptor CXCR4 alone for entry. However, VSV-G-pseudotyped CD134-dependent FIVs complete a single round of infection and subsequent viral assembly unimpeded in these cells, which allows assessment of particle budding under conditions where all viral proteins, including Env, are expressed. We used VSV-G-pseudotyped preparations of fulllength CD134 receptor-dependent FIVs to infect tetherin-expressing CrFK cell lines and then examined viral accumulation in the supernatant. Following infection with the clade A virus FIV PPR , intracellular and supernatant accumulation of viral proteins, including CA and Env, was observed in control CrFK cells (Fig. 5D) . In contrast to their effects on HIV-1 virions and FIV VLPs, fcTetherin SF and fcTetherin LF only mildly inhibited FIV PPR egress (Fig. 5D) . FIV PPR was also only modestly inhibited by hsTetherin and was completely unaffected by cfTetherin. To determine whether this phenotype was strain/clade-specific or a universal mechanism of FIV-mediated tetherin antagonism, a clade C virus, FIV C36 , which is highly pathogenic in vivo (74, 75) , was also tested in single-round particle release assays. It was even less sensitive to tetherin than FIV PPR , with no budding differences in tetherin-expressing cells compared to controls (Fig. 5E) .
Feline tetherin minimally restricts spreading FIV replication. We next examined spreading replication of FIV, using FIV 34TF10 , which utilizes the entry receptor CXCR4 (52, 76) . We employed versions of FIV 34TF10 (Fig. 4B ) with or without repair of the premature stop codon in the OrfA accessory gene (55) . Whereas stable expression of the restriction factor rhesus TRIMCyp reduced viral reverse transcriptase production at all postchallenge time points by approximately 2 log (Fig. 6A) , ectopic tetherin expression reduced peak RT production marginally and did not delay the time course (Fig. 6B and C) . In addition, syncytia formed equivalently in the presence of each of the tetherins (data not shown). OrfA, the only accessory gene yet identified in FIV besides Rev, is required for efficient FIV replication in primary PBMCs, but the mechanism remains unclear (55, (77) (78) (79) (80) (81) (82) (83) . Replication of the parental OrfA(Ϫ) FIV 34TF10 virus was similar to the OrfA(ϩ) virus, which indicates that OrfA is not an antitetherin (Fig. 6B  and C) .
Tetherin antagonism by FIV maps to Env. Given the clear phenotypic disparities that we observed between budding of the full-length viruses and FIV VLPs or FIV vectors that lack genes besides Gag, Gag-Pol, and Rev, as well as the ability of FIV to undergo spreading replication in carnivore tetherin-expressing cells, we proceeded to map the source of tetherin antagonism in the FIV genome. A series of viruses with different complements of viral proteins were compared in single-cycle budding assays. We compared virions generated with pFP93 (which encodes only FIV 34TF10 -derived FIV Gag, Gag-Pol, and Rev) with those generated by pCT5efs, which expresses all FIV 34TF10 viral proteins except the envelope glycoprotein, due to a single frameshift in env (84) . Additionally, we constructed analogous FIV PPR and FIV C36 expression plasmids similarly enabled for producing FIV in human cells by substituting their 5= long terminal repeat (LTR) U3 elements with the human cytomegalovirus immediate early gene promoter (Fig. 4B) . Particle production and release were compared in transfected 293T cells. Normalized to tetherin-negative cells, virions produced by pFP93 and pCT5efs were each impaired, by all tetherins tested, for mature particle release (Fig. 7) .
The env-intact full-length FIVs had markedly different phenotypes. Their particle formation was impaired in the presence of hsTetherin, but enhanced viral budding was actually consistently observed in the presence of cfTetherin and fcTetherin SF (Fig. 7A to  C) . As in the FIV 34TF10 spreading replication experiments, OrfA(ϩ) and OrfA(Ϫ) versions of FIV C36 displayed approximately equivalent sensitivities to tetherin (Fig. 7A) . The enhanced budding of replication-competent FIV was dependent on the tetherin being of carnivore origin; both hsTetherin and an artificial tetherin (artTetherin; see reference 27) blocked budding of FIV PPR and FIV C36 (Fig. 7B and C) . These results strongly implicated FIV Env as the mediator of carnivore tetherin antagonism, so we next directly tested this hypothesis by expressing Env in trans.
FIV Env antagonizes tetherin to enable FIV, but not HIV-1, particle production. We devised plasmids that coexpress Rev and the env alleles of FIV PPR or FIV C36 by replacing the Gag-Pol genes of pFP93 with the respective env segments (Fig. 8A) . Both PPR and C36 Env were processed similarly when expressed alone or in the context of the full-length viral clones in 293T cells (Fig. 8B) . Expression of both FIV PPR and FIV C36 Env caused syncytia in a primary-receptor-dependent manner in 293T cells (Fig. 8C) , demonstrating that the proteins produced are functional.
Viral release assays were performed by cotransfecting pCT5efs
Aϩ with different Env expression plasmids. Supernatant accumulation of bald or VSV-G-pseudotyped particles was markedly reduced in cells expressing any of the three mammalian tetherins (Fig. 8D ). Particles pseudotyped with FIV PPR Env remained sensitive to hsTetherin restriction, with substantially decreased yields in mature particle formation and supernatant capsid accumulation. In contrast, neither cfTetherin nor fcTetherin SF had any effect on FIV PPR Env-pseudotyped virion egress. Moreover, supernatant CA yields were significantly higher for these Env-bear- ing vectors in the presence of either carnivore tetherin, demonstrating again the synergistic augmentation effect that FIV Env and tetherin confer to FIV particle release (Fig. 8D) . FIV C36 Envpseudotyped vector particles also displayed this pattern of increased supernatant capsid accumulation and equivalent reverse transcriptase activity in cfTetherin-and fcTetherin SF -expressing cells (Fig. 8D) .
Primate lentiviral tetherin antagonists (Vpu, Nef, and Env) principally act to remove tetherin from sites of virus release at the cell surface, although the mechanisms may vary (10, 85) . Thus, these antagonists can rescue particle release of other enveloped viruses as well as the virus that encodes them. Both SIVtan and HIV-2 Env can rescue HIV-1 particles in trans by downregulating cell surface tetherin, primarily by sequestering it within intracellular compartments (3, 17, 18) . To test whether FIV Env acts similarly, we examined HIV-1 budding. Surprisingly, in contrast to their effects on FIV, the FIV envelope glycoproteins were unable to rescue HIV-1 particle release (Fig. 8E) . These results raise the interesting possibility that unlike HIV-2 Env (3, 18), incorporation of FIV Env into the particle is required to activate the tetherin evasion mechanism.
To confirm that FIV Env is not incorporated functionally into HIV-1 particles, HIV-1 and FIV reporter viruses were pseudotyped and their titers were determined on feline cells that express the FIV primary receptor CD134 (Table 1) . These experiments yielded clear results that were moreover strongly consistent between the two FIV Env glycoproteins: PPR Env and C36 Env pseudotyping produced FIV particles that had 343-fold-and 338-fold-greater FIV Env/VSV-G infectivity ratios, respectively, than HIV-1 particles (Table 1) .
FIV Env does not modulate intracellular levels or cell surface trafficking of tetherin. We found that CrFK cells infected with FIV PPR (introduced into these cells via VSV-G pseudotyping to establish proviruses) expressed FIV well (flow cytometry data are shown in Fig. 9 ; immunoblotting is not shown), but changes in total intracellular tetherin levels compared to uninfected cells were not evident (Fig. 9A and B) . FIV C36 produced a minor decrease in bulk carnivore tetherin intracellular levels but did not affect human tetherin (Fig. 9A and B) . We considered that FIV C36 may specifically deplete the cell surface pool of tetherin or otherwise prevent its accumulation at the cell surface, as has been documented for HIV-1 Vpu (5, 86-88) and HIV-2 Env (3). Therefore, we specifically imaged cell surface tetherin in nonpermeabilized cells. However, in cells transfected with full-length FIV plasmids, normal trafficking to the cell surface was observed for tetherin proteins from all three species (Fig. 9C) . Transient expression of HIV-1 Vpu decreased cell surface levels of hsTetherin, whereas FIV Env, either alone or in the presence of all viral proteins, did not alter the cell surface pool of fcTetherin SF (Fig. 9D) .
For HIV-2 Env, tetherin antagonism requires endocytic motifs in the envelope transmembrane (TM) domain cytoplasmic tail, which is consistent with the cell-surface downregulation mechanism (3, 18) . While the FIV TM cytoplasmic tail is significantly shorter than those found in the primate lentiviruses (89) , it does contain the conserved GYXX⌽ endocytosis motif also present in all primate lentivirus Envs (90) . The lack of tetherin downregulation that we observed suggests that FIV Env endocytic sorting is dispensable for tetherin antagonism. To test directly the role of cytoplasmic tail elements, a premature stop codon was introduced into FIV C36 Env (C36 TM⌬43), removing a majority of the cytoplasmic tail (43 of 53 amino acids) including the GYTVI endocytosis motif. A virus with a furin cleavage site mutation was also constructed (C36 furin mutant). Wild-type and Env-mutant FIV C36 viruses were pro- duced in control and fcTetherin SF -expressing 293T cells, and the resulting supernatants were tested for reverse transcriptase activity and capsid accumulation. Despite low intracellular Env levels, removal of the TM cytoplasmic tail did not reduce Env protection of FIV C36 budding in the presence of fcTetherin SF (Fig. 10) . Mutation of the furin cleavage site resulted in accumulation of only the uncleaved Env precursor. Notably, however, this virus budded as efficiently as wild-type virus in the presence of tetherin (Fig. 10 ). These results demonstrate that FIV Env antagonism of fcTetherin does not proceed via the cell surface depletion mechanism used by primate lentiviral tetherin antagonists. Moreover, neither the cytoplasmic tail endo- cytosis motifs nor processing of the Env precursor into SU and TM are required for efficient tetherin counteraction.
FIV Env and Ebola virus GP rescue distinct subsets of viral particles from tetherin restriction. The foregoing results suggest that FIV Env possesses an important similarity to Ebola virus Env glycoprotein (Ebola GP)-antagonizing tetherin without cell surface downregulation (60, 91)-as well as a key difference: inability to act in trans. Ebola GP rescues budding of heterologous viral particles, including Vpu-deleted HIV-1 (6, 60) . We tested their capacity to rescue budding of Env-deficient FIV and Vpu-deficient HIV-1. Consistent with the notion that both FIV Env and Ebola GP act locally at the sites of viral budding, but also raising the additional idea that HIV-1 and FIV bud from distinct membrane environments, each glycoprotein displayed clear virus-specific antagonism. FIV Env was again able to rescue budding of its cognate viral particles only, whereas Ebola GP efficiently rescued HIV-1 but not FIV particle budding (Fig. 11A and B) . Moreover, the two viral envelope glycoproteins were further differentiated by their ability to counteract divergent tetherin proteins. Ebola GP antagonized both hsTetherin and fcTetherin SF (Fig. 11B) , and it has been documented previously to have activity even against artTetherin (60) . FIV is very clearly able to counteract only carnivore tetherins (Fig. 7, 8D , and 11A).
DISCUSSION
Primates and carnivores exhibit commonalities and differences in the case of retroviral restrictions. For example, both mammalian orders have active APOBEC3 gene repertoires, while TRIM5 restriction is absent in the Carnivora (92) . For tetherin, the extent to which nonprimate lentiviruses actually encounter the restriction in their host species and mount similar defenses has been unclear. The lentiviral restriction factor repertoire of Felis catus is of interest because, like Homo sapiens and unlike most simian lentivirus host species, the cat is afflicted with a lentivirus with which it has not yet reached a nonpathogenic evolutionary equilibrium.
The location of the initiator methionine for feline tetherin has been uncertain, as proteins corresponding to fcTetherin SF and fcTetherin LF have been reported and shown to have antiviral activity (42) (43) (44) . Our 5= RACE analyses confirm that only fcTetherin SF mRNAs are produced in primary feline cells and feline cell lines, so that feline tetherin has a shortened N-terminal cytoplasmic tail compared to the human, mouse, and canine tetherin homologues. We could not detect the most plausible alternative, i.e., mRNA splicing that utilizes the AG dinucleotide generated by the presumed ancient deletion of a T nucleotide as a splice acceptor (Fig.  2) , which could in theory generate the hypothesized fcTetherin LF . By characterizing the tetherin mRNA sequences from the tiger, cat, dog, and ferret, we show that this single-nucleotide deletion in the initiator methionine of fcTetherin LF is felid specific. This truncation is lacking in the Caniformia suborder as evidenced by the ferret and dog mRNAs; one plausible evolutionary scenario is that it resulted from positive selection to remove an N terminus motif targeted by an ancestral Feliformia species pathogen. A deletion of the G/D 14 DIWK 18 motif during hominid evolution removed the Nef target sequence, perhaps due to a selective sweep by a lentivirus that encoded a Nef or Nef-like protein, and presumably provided pressure for the alternative antitetherin Vpu to arise (10, 15, 16) . The tiger (Panthera genus) and domestic cat (Felis genus) span maximum phylogenetic distance within the Felidae, with an estimated branch point about 10.8 MYA (66) . Restoring the presumed ancestral N terminus of feline tetherin did not result in altered anti-FIV activity (Fig. 4 to 6 ). In addition to the evident antiquity of the single-nucleotide deletion (Fig. 2B) , this observation suggests that the truncation did not result from selective culling by FIV or similar ancestral feline lentiviruses per se. The N-terminal truncation does yield a protein with slower turnover than the longer form, which may have physiological consequences (compare SF and LF in Fig. 5A and B) . In testing the presumed ancient long form, it cannot be excluded that consequential sense mutations occurred in the other 18 codons of the long-form tail downstream of the ATG, but since the tiger and cat nucleotide sequences are identical here, they would have to be similarly ancient.
Type I interferon treatment blocks FIV infection of domestic cat PBMCs (Fig. 1A) , and tetherin transcripts were upregulated under the same conditions (Fig. 2D) , which raised the possibility that tetherin might be at least one of the consequential interferonstimulated genes (ISGs). However, even when tetherin was ectopically expressed at supranormal levels (compare Fig. 2D with Fig.  5B ), budding of full-length primary FIV clones was either partially reduced (FIV PPR ) or unaffected (FIV C36 ). The FIV replication block triggered by type I interferon is therefore likely due to upregulation of other antiviral ISGs.
The disparity in tetherin sensitivity between infectious FIV and FIV vectors (or VLPs) provides strong evidence that a tetherin antagonist is encoded by the FIV genome. A previous study did not find evidence for an antagonist and suggested that the lack of restriction to spreading FIV replication is due to enhanced cell-tocell spread (42) . Consistent with observations by Celestino et al. on fcTetherin SF (44), we determined that when supplied in trans, FIV Env antagonizes both fcTetherin SF and C. familiaris tetherin. However, we show that this is only for cognate (FIV) particles (Fig.  8D ). Celestino and colleagues also reported that fcTetherin SF is coprecipitated from cells by antibody to FIV Env (44) . A single clade A strain (FIV Petaluma ) was tested, and the mechanism for Env antagonism was not further explored. We demonstrate here that this Env-specific antagonism is conserved between clades, using FIV PPR (clade A) and FIV C36 (clade C). While the absence of specific antibodies presently hinders determination of the tissue expression profile of tetherin in the cat in vivo, the observation by us and others (44) that FIV envelope glycoprotein can act as an effective antagonist suggests that FIV indeed encounters and evades tetherin in vivo.
We additionally report here enhanced budding of env-intact but not env-deficient FIV in the presence of tetherin (Fig. 7) . This striking phenomenon, which suggests that FIV has evolved to coopt tetherin, is consistent with our finding that FIV does not evade restriction by degrading the protein or removing it from the cell surface. Instead, we show that evasion of tetherin restriction requires specific incorporation of FIV Env into FIV particles. Env cannot act in trans to rescue noncognate particles. We propose that FIV envelope glycoproteins are triggered to engage tetherin coincident with or after virion incorporation, thereby shielding the nascent particle. The degree of restriction antagonism by Env correlates with the efficiency of viral particle incorporation. We note that tetherin enhanced budding most dramatically for FIVs that express their native Env proteins (Fig. 7) . Pseudotyping of FIV 34TF10 particles with FIV PPR and FIV C36 Envs resulted in an intermediate phenotype whereby mature particle formation was comparable to control (tetherin-absent) levels, and capsid levels in supernatant were still increased in the presence of fcTetherin (Fig. 8D) . In contrast, HIV-1 is minimally pseudotypeable by FIV envelope glycoproteins (Table 1 ) and was not rescued in trans by FIV PPR or FIV C36 envelope (Fig. 8E) . The envelope glycoproteins of SIVtan, HIV-2, and Ebola virus are tetherin antagonists, but expression of each of these envelope glycoproteins rescues budding of HIV-1 (3, 6, 18, 60) . This difference demarcates these proteins from FIV Env, which rescues budding of cognate particles only. Some main properties of FIV Env versus other antagonists are summarized in Table 2 .
Examining the interplay between FIV Env and tetherin also revealed an interesting negative impact of FIV Env expression on FIV budding. This phenomenon is most clearly seen in Fig. 10 (compare lane 3 with lanes 1 and 5). Budding of env-intact FIV C36 was significantly reduced compared to env-deficient virions (FP93), virions defective for SU-TM cleavage, and virions with a deletion of the TM cytoplasmic domain (Fig. 10, lanes 1 and 7) . Importantly, expression of tetherin restores budding of fulllength FIV C36 to levels observed in the absence of Env, suggesting that the two phenotypes are linked. We speculate that FIV Env may constrain budding of FIV particles in situations where tetherin expression is low, yet it may serve to enable efficient budding in cells expressing high levels of tetherin. Tetherin would by this reasoning act akin to a licensing factor for FIV, helping to maintain a balance of cell-free and cell-associated particle formation that promotes viral spread in the in vivo environment. In this scenario, FIV Env has evolved to both evade and exploit this protein, allowing us to suggest that tetherin is both a restriction factor and a cofactor for this lentivirus.
The observation that FIV is able to counteract both cfTetherin and fcTetherin but remains sensitive to hsTetherin and the completely artificial tetherin ( Fig. 7 and 8 ) implies that Env may interact directly or indirectly with fcTetherin, which is supported by the previous observation that FIV Env coimmunoprecipitated from cells with tetherin (44) . Combined with the evidence that FIV, unlike primate lentiviruses, does not significantly degrade tetherin or downregulate it from the cell surface (Fig. 9) , these results suggest that Env is acting locally on a per-particle basis at the point of viral budding to affect tetherin sensitivity, rather than exerting a cell-wide phenotype. FIV Env-directed assembly may exclude tetherin from virions or virion assembly sites or direct assembly to tetherin-negative membrane domains. This "local" point-of-assembly model may also apply to Ebola virus GP, which has previously been described to counteract tetherin without removing it from the cell surface (60, 91) . There are important differences however, in that that Ebola virus GP and FIV Env selectively rescued only HIV-1 or FIV, respectively. While Ebola virus GP pseudotypes HIV-1 and FIV well (93, 94) , FIV Env pseudotypes only FIV (Table 1) . Thus, the mirrored tetherin antagonism phenotypes of these two glycoproteins do not depend on the variable of particle incorporation alone. Investigating how FIV Env distinguishes and rescues only cognate particles while cooperating in particle formation at the plasma membrane has the potential to advance understanding of retroviral assembly and innate immunity circumvention. 
